PREPARATION AND UTILIZATION OF LEUKOCYTE POOR APHERESIS PLATELETS

被引:10
作者
ANDERSON, KC
GORGONE, BC
WAHLERS, E
COOK, J
BARRETT, B
ANDERSEN, J
机构
[1] Divisions of Tumor Immunology and Biostatistics, Dana-Farber Cancer Institute, the Department of Medicine, Boston, MA 02115
来源
TRANSFUSION SCIENCE | 1991年 / 12卷 / 03期
关键词
D O I
10.1016/0955-3886(91)90125-M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Efficiency of collection of apheresis platelets was found to be equivalent (approximately 50%) with the COBE 2997, the Fenwal CS3000, Haemonetics V50 or COBE Spectra(TM) cell separators. A minor fraction (1.5-3.5%) of 6466 consecutive transfusions of apheresis platelets were complicated by febrile transfusion reactions (FTRs). There was a 12.1% incidence of second FTRs following an initial reaction. Centrifugation, filtration, or the provision of platelets harvested on the COBE Spectra(TM) reduced the incidence of subsequent FTRs to less-than-or-equal-to 3.1% in patients with two prior FTRs. Leukocyte content in apheresis platelets ranged from 5 x 10(5) in COBE Spectra(TM) apheresis platelets to 10(9) in platelets from the Fenwal CS3000 or COBE 2997. Filtered platelets from the Haemonetics V50 were as leukopoor as COBE Spectra(TM) apheresis platelets, but centrifugation or filtration of other apheresis platelets did not achieve equivalent leukodepletion. These results suggest that (1) FTRs are rare after transfusion of apheresis platelets; and (2) provision of either platelets from the COBE Spectra(TM) or other apheresis platelets which have been centrifuged or filtered can avoid FTRs in the majority of patients with a history of repeated prior reactions.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 34 条
  • [1] Snyder, Clinical use of white cell poor components, Transfusion, 29, pp. 568-571, (1989)
  • [2] Anderson, Weinstein, Graft versus host disease after transfusion, N Engl J Med, 323, pp. 315-321, (1990)
  • [3] Blumberg, Heal, Transfusion and host defenses against cancer recurrence and infection, Transfusion, 29, pp. 236-245, (1989)
  • [4] De Rie, van der Plas-van Dalen, Englefriet, von dem Borne, The serology of febrile transfusion reactions, Vox Sang, 49, pp. 126-134, (1985)
  • [5] Heinrich, Mueller-Eckhardt, Stier, The specificity of leukocyte and platelet alloantibodies in sera of patients with nonhemolytic transfusion reactions. Absorption and elution studies, Vox Sang, 25, pp. 442-456, (1973)
  • [6] Payne, The association of febrile transfusion reactions with leuko-agglutinins, Vox Sang, 2, pp. 233-241, (1957)
  • [7] Brubaker, Clinical significance of white cell antibodies in febrile non-hemolytic transfusion reactions, Transfusion, 30, pp. 733-737, (1990)
  • [8] Menitove, McElligott, Aster, Febrile transfusion reaction: what blood component should be given next?, Vox Sang, 42, pp. 318-321, (1982)
  • [9] Chambers, Kruskall, Pacini, Donovan, Febrile reactions after platelet transfusion: the effect of single versus multiple donors, Transfusion, 30, pp. 219-221, (1990)
  • [10] Fisher, Chapman, Tung, Morris, Alloimmunization to HLA antigens following transfusion with leukocytepoor and purified platelet suspensions, Vox Sang, 49, pp. 331-335, (1985)